Fig. 1

Overview of the MTB workflow. Each patient case was discussed (1) during the preparatory meeting. The molecular pathology team performed genetic analyses and clinical annotations according to MTB recommendations (2). A second discussion was conducted after the results were analyzed (3), but within the framework of the preparatory meeting. Finally, a therapeutic proposal was finalized (4), and reported back to the treating oncologist at the MTB session (5)